Source document
Joint Annual Interagency Coordination Report, FY2025 (Texas Government Code 531.103)
Has everything in it been taken?
CompleteReviewed 10 Oct 2026
Reviewed. Everything in it that belongs in the tables has been taken.
What the document holds
Joint Interagency Coordination Report, fiscal year 2025 (6 pp., revised 16 Jan 2026; now under Texas Government Code 544.0051(f)): coordination activities; OIG and MFCU key metrics and significant OIG/MFCU cases (out of scope); Healthcare Program Enforcement Division table (cases opened 83, closed 86, pending 355, recovered $71,605,100); two significant HPED settlements; ongoing cases without amounts. Recovery total already recorded. Added the three case counts and the Molina settlement (relator portion) as a case. Not added as a case: BioReference Laboratories ($4.2 million, state and federal portions only). Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 7 cases (1 settlements, 6 pending government suits or claims). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties. Added BioReference Laboratories ($4.2 million, state and federal portions only) and the first appearances of six ongoing matters (two adolescent medicine providers, BMS and Sanofi-Aventis, AstraZeneca kickbacks, Eli Lilly, pediatric dentists and marketers, Planned Parenthood); OIG administrative and MFCU criminal items remain out of scope.
What it supports
13 rows on this site come from this document. Each one opens with the page and the exact words.
Numbers (4)
- Cases handled by the agency enforcing a reward lawItem: Opened83 casesFY2025 · Texas HHS OIG / Texas AG 2025Final figureUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Cases handled by the agency enforcing a reward lawItem: Closed86 casesFY2025 · Texas HHS OIG / Texas AG 2025Final figureUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Cases handled by the agency enforcing a reward lawItem: Pending355 casesFY2025 · Texas HHS OIG / Texas AG 2025Final figureUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Total recoveriesUSD 71,605,100FY2025 · Texas HHS OIG / Texas AG 2025Final figureUnited States · Texas Medicaid Fraud Prevention Act qui tam
Cases and awards (8)
- BioReference Laboratories, Inc.Money collected USD 4,200,000SettledUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Bristol-Myers Squibb Company and Sanofi-Aventis U.S. LLCPendingUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Eli LillyPendingUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Planned ParenthoodPendingUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Two adolescent medicine providers (not named in the report)PendingUnited States · Texas Medicaid Fraud Prevention Act qui tam
- AstraZenecaPendingUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Pediatric dentists and dental marketing companies (not named in the report)PendingUnited States · Texas Medicaid Fraud Prevention Act qui tam
- Molina Healthcare, Inc.2025 · Money collected USD 40,000,000SettledUnited States · Texas Medicaid Fraud Prevention Act qui tam
About the document
What it covers Texas Medicaid fraud enforcement for FY2025: OIG, Medicaid Fraud Control Unit and the Attorney General's Civil Medicaid Fraud Division (cases opened/closed/pending, total amount recovered, significant TMFPA settlements)
Notes oig.hhs.texas.gov did not answer scripted requests; copy retrieved from the Wayback Machine (id_). Publication month not printed; year given.
Source id usa-tx-joint-coord-report-fy2025 · accessed 5 Oct 2026